Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: Effect of age related factors and service organisation

Thorax

Volumn 61, Issue 10, 2006, Pages 843-848

  Connolly, M J ^a,c   Lowe, D ^b   Anstey, K ^b   Hosker, H S R ^b   Pearson, M G ^b   Roberts, C M ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ACIDOSIS; AGE SPECIFIC CARE; AGED; ARTICLE; BLOOD GAS ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; ELDERLY CARE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL ORGANIZATION; HOSPITAL SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PROFESSION; MORTALITY; PRIORITY JOURNAL;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD GAS ANALYSIS; DELIVERY OF HEALTH CARE; FEMALE; FORCED EXPIRATORY VOLUME; GREAT BRITAIN; HEALTH RESOURCES; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENCE; REGRESSION ANALYSIS;

EID: 33750030248     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.054924     Document Type: Article

References (22)

1. Soriano JB, Maier WC, Egger P, et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000;55:789-94.
2. National Institute for Clinical Excellence (NICE). Chronic obstructive pulmonary disease: national clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl I):1-232.
3. Renwick DS, Connolly MJ. Prevalence and treatment of chronic airways obstruction in adults over the age of 45. Thorax 1996;51:164-8.
4. British Thoracic Society. The burden of lung disease, 2nd ed. London: British Thoracic Society, 2006.
5. Office for National Statistics. Mortality statistics: cause, 1999, DH2 (No 26). London: HMSO, 2000.
6. Murray CJ, Lopez AD. Evidence-based health policy: lessons from the Global Burden of Disease Study. Science 1996;274:740-3.
7. Roberts CM, Lowe D, Bucknall CE, et al. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax 2002;57:137-41.
8. Roberts CM, Ryland I, Lowe D, et al. Audit of acute admissions of COPD: standards of care and management in the hospital setting. Eur Respir J 2001;17:343-9.
9. Roberts CM, Barnes S, Lowe D, et al. Evidence of a link between mortality in acute COPD and hospital type and resources. Thorax 2003;58:947-9.
10. Price L, Lowe D, Hosker H, et al. UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admissions for acute COPD exacerbation. Thorax 2006;61:837-42.
11. http://www.statistics.gov.uk/STATBASE/ssdataset.asp?vlnk=9056.
12. Wood-Baker RR, Gibson PG, Hannay M, et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2003: Issue 3.
13. Singh JM, Palda VA, Stanbrook MB, et al. Corticosteroid therapy for patients with acute exacerbations of COPD; a systematic review. Arch Intern Med 2002;162:2527-36.
14. Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulised budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 2002;165:698-703.
15. Davies L, Angus RM, Calverley PMA. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease; a prospective randomised controlled trial. Lancet 1999;354:456-60.
16. Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1999;340:1941-7.
17. Thompson WH, Nielson CP, Carvalho P, et al. Controlled trial of oral prednisolone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996;154:407-12.
18. Ram FSM, Picot J, Lightowler J, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews Issue 3, 2004.
19. Skwarska E, Cohen G, Skwarski KM, et al. Randomised controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease. Thorax 2000;55:907-12.
20. Davies L, Wilkinson M, Bonner S, et al. "Hospital at home" versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial. BMJ 2000;321:1265-8.
21. Ojoo X, Moon T, McGlone S, et al. Patients' and carers' preferences in two models of care for acute exacerbations of COPD: results of a randomised controlled trial. Thorax 2002;57:167-9.
22. Hernandez C, Cacas A, Escarrbill J, et al. Home hospitalisation of exacerbation chronic obstructive pulmonary disease patients. Eur Respir J 2003;21:58-67.